{
    "clinical_study": {
        "@rank": "16739", 
        "biospec_descr": {
            "textblock": "Blood samples"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Study of persistent platelet reactivity during acute coronary syndrome. Patients are\n      included at admission to the hospital. Platelet aggregation is evaluated by platelet\n      function testing after blood sampling during hospitalization. No changes in treatment is\n      planned."
        }, 
        "brief_title": "Persistent Platelet Reactivity in Acute Coronary Syndrome", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Coronary Syndrome", 
        "condition_browse": {
            "mesh_term": "Acute Coronary Syndrome"
        }, 
        "detailed_description": {
            "textblock": "Blood samples are performed on day 2 and 4 and collected with usual blood samples and\n      analyzed by the laboratory. Maximal aggregation intensity and velocity  are measured by\n      light transmission aggregometry induced by arachidonic acid (AA) or adenosine diphosphate\n      (ADP). Platelet function analyzer will be also used. No changes in treatment in response to\n      the results is planned."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  acute coronary syndrome with elevation in troponin\n\n        Exclusion Criteria:\n\n          -  anticoagulant treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Acute coronary syndrome"
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02038309", 
            "org_study_id": "PPRACS"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Acute coronary syndrome", 
            "persistent platelet reactivity"
        ], 
        "lastchanged_date": "January 15, 2014", 
        "location": {
            "contact": {
                "email": "dillingerjg@aol.com", 
                "last_name": "JEAN-GUILLAUME DILLINGER, MD", 
                "phone": "33620393260"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75010"
                }, 
                "name": "Department of Cardiology - Lariboisiere Hospital"
            }, 
            "investigator": {
                "last_name": "Jean-Guillaume Dillinger, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Persistent Platelet Reactivity in Acute Coronary Syndrome", 
        "other_outcome": [
            {
                "description": "Major cardiovascular and cerebrovascular events : death, myocardial infarction, stroke, rehospitalisation and bleeding (academic research consortium) events at 1 year", 
                "measure": "Major cardiovascular and cerebrovascular events (MACCE)", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "description": "measurement during primary PCI on admission", 
                "measure": "microvascular resistance index", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }
        ], 
        "overall_official": {
            "affiliation": "Department of Cardiology - Lariboisiere Hospital - APHP", 
            "last_name": "Patrick Henry, MD-PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Institutional Ethical Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Light transmission aggregometry following exposition to arachidonic acid 0.5mg/ml during the acute phase (day2-day 5)", 
            "measure": "maximum aggregation intensity", 
            "safety_issue": "No", 
            "time_frame": "day 2"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02038309"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hopital Lariboisi\u00e8re", 
            "investigator_full_name": "Dr Jean-Guillaume DILLINGER", 
            "investigator_title": "Department of Cardiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Light transmission aggregometry following exposition to adenosine diphosphate during the acute phase (day2-day 5)  and during the chronic phase (day 30-day 60)", 
                "measure": "Maximum aggregation intensity", 
                "safety_issue": "No", 
                "time_frame": "Day 2"
            }, 
            {
                "description": "Light transmission aggregometry following exposition to arachidonic acid 0.5mg/ml during the chronic phase (day 30-day 60)", 
                "measure": "Maximum aggregation intensity", 
                "safety_issue": "No", 
                "time_frame": "Chronic phase (day 30 to day 60)"
            }
        ], 
        "source": "Hopital Lariboisi\u00e8re", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hopital Lariboisi\u00e8re", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Year", 
        "verification_date": "January 2014"
    }
}